1,904
Views
1
CrossRef citations to date
0
Altmetric
Gastroenterology

Costs of colorectal cancer screening with colonoscopy, including post-endoscopy events, among adults with Medicaid insurance

, ORCID Icon, , &
Pages 793-801 | Received 30 Sep 2021, Accepted 01 Mar 2022, Published online: 15 Mar 2022

References

  • Ward EM, Sherman RL, Henley SJ, et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20-49 Years. J Natl Cancer Inst. 2019;111(12):1279–1297.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin. 2020;70(1):7–30.
  • Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA A Cancer J Clin. 2020;70(3):145–164.
  • SEER. Cancer Stat Facts: Colorectal Cancer. 2020. [cited 2020 August]; Available from: https://seer.cancer.gov/statfacts/html/colorect.html.
  • U. S. Preventive Services Task Force. Screening for colorectal cancer: US preventive services task force recommendation statement. Jama. 2016;315(23):2564–2575.
  • Klabunde CN, Cronin KA, Breen N, et al. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1611–1621.
  • Wheeler SB, Kuo T-M, Meyer AM, et al. Multilevel predictors of colorectal cancer testing modality among publicly and privately insured people turning 50. Prev Med Rep. 2017;6:9–16.
  • Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687–696.
  • Reumkens A, Rondagh EJA, Bakker MC, et al. Post-colonoscopy complications: a systematic review, time trends, and meta-analysis of population-based studies. Am J Gastroenterol. 2016;111(8):1092–1101.
  • Wang L, Mannalithara A, Singh G, et al. Low rates of gastrointestinal and non-gastrointestinal complications for screening or surveillance colonoscopies in a population-based study. Gastroenterology. 2018;154(3):540–555. e8.
  • Chokshi RV, Hovis CE, Hollander T, et al. Prevalence of missed adenomas in patients with inadequate bowel preparation on screening colonoscopy. Gastrointest Endosc. 2012;75(6):1197–1203.
  • Pyenson B, Scammell C, Broulette J. Costs and repeat rates associated with colonoscopy observed in medical claims for commercial and Medicare populations. BMC Health Serv Res. 2014;14(1):92.
  • Meester RGS, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015;121(13):2281–2285.
  • Wyatt TE, Pernenkil V, Akinyemiju TF. Trends in breast and colorectal cancer screening among U.S. adults by race, healthcare coverage, and SES before, during, and after the great recession. Prev Med Rep. 2017;7:239–245.
  • Joseph DA, King JB, Dowling NF, et al. Vital signs: colorectal cancer screening test use – United States, 2018. MMWR Morb Mortal Wkly Rep. 2020;69(10):253–259.
  • de Moor JS, Cohen RA, Shapiro JA, et al. Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage. Preventive Medicine. 2018; Jul112:199–206.
  • Knight JR, Kanotra S, Siameh S, et al. Understanding barriers to colorectal cancer screening in Kentucky. Prev Chronic Dis. 2015;12:E95.
  • Hendryx M, Luo J. Increased cancer screening for low-income adults under the affordable care act Medicaid expansion. Med Care. 2018;56(11):944–949.
  • Lyu W, Wehby GL. The impacts of the ACA Medicaid expansions on cancer screening use by primary care provider supply. Med Care. 2019;57(3):202–207.
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619.
  • Scheiman JM, Fendrick AM, Nuliyalu U, et al. Surprise billing for colonoscopy: the scope of the problem. Ann Intern Med. 2021;174(3):426–428.
  • Consumer Price Index details report tables [cited 2020. 1 October]; Available from: https://www.bls.gov/cpi/home.htm.
  • Zerhouni YA, Trinh Q-D, Lipsitz S, et al. Effect of Medicaid expansion on colorectal cancer screening rates. Dis Colon Rectum. 2019;62(1):97–103.
  • Fisher DA, Princic N, Miller-Wilson LA, et al. Healthcare costs of colorectal cancer screening and events following colonoscopy among commercially insured average-risk adults in the United States. Curr Med Res Opin. 2021;17:1–71.
  • Subramanian S, Tangka FKL, Hoover S, et al. Costs of colorectal cancer screening provision in CDC's colorectal cancer control program: comparisons of colonoscopy and FOBT/FIT based screening. Eval Program Plann. 2017;62:73–80.
  • Chukmaitov A, Bradley CJ, Dahman B, et al. Association of polypectomy techniques, endoscopist volume, and facility type with colonoscopy complications. Gastrointest Endosc. 2013;77(3):436–446.
  • Chukmaitov A, Dahman B, Bradley CJ. Outpatient facility volume, facility type, and the risk of serious colonoscopy-related adverse events in patients with comorbid conditions: a population-based study. Int J Colorectal Dis. 2019;34(7):1203–1210.